Biochemical investigations demonstrated persistent hypercalcemia, elevated parathyroid hormone, and significantly raised fasting gastrin levels whilst off high-dose PPI, raising suspicion for MEN1 syndrome. This evidence concerns the gene PTH and Hypercalcemia.